Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gynecology

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 61 articles:
HTML format



Single Articles


    November 2021
  1. ISONO R, Tsubamoto H, Ueda T, Takimoto Y, et al
    Itraconazole Inhibits Intracellular Cholesterol Trafficking and Decreases Phosphatidylserine Level in Cervical Cancer Cells.
    Anticancer Res. 2021;41:5477-5480.
    PubMed     Abstract available


    October 2021
  2. NOSAKA K, Suzuki S, Yoshikawa T, Shimomura M, et al
    Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer.
    Anticancer Res. 2021;41:4741-4751.
    PubMed     Abstract available


  3. GADDUCCI A, Cosio S
    Randomized Clinical Trials and Real World Prospective Observational Studies on Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Ovarian Carcinoma: A Critical Review.
    Anticancer Res. 2021;41:4673-4685.
    PubMed     Abstract available


  4. LUENGAS-WUERZINGER V, Rawert F, CLAssEN-VON Spee S, Baransi S, et al
    Role of the Cardiophrenic Lymph Node Status After Neoadjuvant Chemotherapy in Primary Advanced Ovarian Cancer.
    Anticancer Res. 2021;41:5025-5031.
    PubMed     Abstract available


    September 2021
  5. SHIN W, Noh JJ, Baek SH, Kim BG, et al
    Real-world Experience of Niraparib in Newly-diagnosed Epithelial Ovarian Cancer.
    Anticancer Res. 2021;41:4603-4607.
    PubMed     Abstract available


  6. CHOI KH, Kim H, Bae GE, Lee SH, et al
    Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
    Anticancer Res. 2021;41:4587-4601.
    PubMed     Abstract available


  7. GADDUCCI A, Ugolini C, Cosio S, Vistoli F, et al
    Primary Perivascular Epithelioid Cell Tumor (PEComa) of the Ovary: A Case Report and Review of the Literature.
    Anticancer Res. 2021;41:4483-4488.
    PubMed     Abstract available


  8. LAI J, Tong C, Chien JR
    Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma.
    Anticancer Res. 2021;41:4417-4422.
    PubMed     Abstract available


  9. RADES D, Kopelke S, Soror T, Schild SE, et al
    Sleep Disorders Prior to Adjuvant Radiation Therapy for Gynecological Malignancies.
    Anticancer Res. 2021;41:4407-4410.
    PubMed     Abstract available


  10. MIYAKE R, Yamanaka S, Matsubara S, Mabuchi S, et al
    Preclinical Activity of Plitidepsin Against Clear Cell Carcinoma of the Ovary.
    Anticancer Res. 2021;41:4277-4285.
    PubMed     Abstract available


  11. ISONO R, Tsubamoto H, Inoue K, Ueda T, et al
    Itraconazole Increases Resolvin E3 Concentration and 12/15-lipoxygenase Inhibitor Attenuates Itraconazole Cytotoxicity in Cervical Cancer Cells.
    Anticancer Res. 2021;41:4271-4276.
    PubMed     Abstract available


  12. CARUSO G, Palaia I, DI Donato V, Pernazza A, et al
    Radical Surgery After Neoadjuvant Chemotherapy for Locally Advanced Neuroendocrine Cancer of the Cervix.
    Anticancer Res. 2021;41:4431-4438.
    PubMed     Abstract available


    August 2021
  13. AKAZAWA M, Hashimoto K, Lee SL, Liu WM, et al
    Learning Curve of Robotic-assisted Hysterectomy With Pelvic Lymphadenectomy for Early Stage Endometrial Cancer: Analysis of 81 Cases.
    Anticancer Res. 2021;41:4173-4178.
    PubMed     Abstract available


  14. YOSHIDA K, Kondo E, Nimura R, Maki S, et al
    Laparoscopic Versus Robotic Hysterectomy in Obese Patients With Early-stage Endometrial Cancer: A Single-centre Analysis.
    Anticancer Res. 2021;41:4163-4167.
    PubMed     Abstract available


  15. KONDO E, Nimura R, Maki S, Kaneda M, et al
    Prognostic Benefit of >/=6 Cycles of Neoadjuvant Chemotherapy for Advanced Ovarian, Tubal, and Peritoneal Cancers.
    Anticancer Res. 2021;41:4157-4161.
    PubMed     Abstract available


  16. KUBO-KANEDA M, Kondo E, Nimura R, Maki S, et al
    Effectiveness of Laparoscopic Combined Retroperitoneal and Transperitoneal Approach in Para-aortic Lymphadenectomy for Endometrial Cancer.
    Anticancer Res. 2021;41:4151-4155.
    PubMed     Abstract available


  17. TAMURA D, Maeda D, Enomoto K, Sato H, et al
    Severe Abdominal Recurrence of Low-grade Endometrial Stromal Sarcoma After Hysteroscopic Surgery.
    Anticancer Res. 2021;41:4013-4016.
    PubMed     Abstract available


    July 2021
  18. MIRANDA A, Jurgensen C, Chekerov R, Chopra S, et al
    EUS-guided Transgastric Drainage to Manage a Postoperative Pancreatic Fistula After Distal Pancreatectomy and Splenectomy in Recurrent Ovarian Cancer: A Case Report.
    Anticancer Res. 2021;41:3649-3656.
    PubMed     Abstract available


  19. KIESEL M, Sauer S, Lob S, Herbert SL, et al
    Total Mesometrial Resection With (Neo)Adjuvant Chemotherapy in Locally Advanced Cervical Cancer: A Tumor Response Score.
    Anticancer Res. 2021;41:3543-3560.
    PubMed     Abstract available


  20. SHAM N, Qin C, Zhu Z, Redington CG, et al
    Raspberry Extract With Potential Antitumor Activity Against Cervical Cancer.
    Anticancer Res. 2021;41:3343-3348.
    PubMed     Abstract available


  21. FRIEDRICH M, Friedrich D, Kraft C, Rogmans C, et al
    Multimodal Treatment of Primary Advanced Ovarian Cancer.
    Anticancer Res. 2021;41:3253-3260.
    PubMed     Abstract available


    June 2021
  22. COLLINS A, Spooner S, Horne J, Chainrai M, et al
    Peri-operative Variables Associated With Prolonged Intensive Care Stay Following Cytoreductive Surgery for Ovarian Cancer.
    Anticancer Res. 2021;41:3059-3065.
    PubMed     Abstract available


  23. EGGER EK, Liesenfeld H, Stope MB, Recker F, et al
    Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
    Anticancer Res. 2021;41:3037-3043.
    PubMed     Abstract available


  24. WATANABE K, Hayashi T, Katsumata M, Sano K, et al
    Development of Uterine Leiomyosarcoma During Follow-up After Caesarean Section in a Woman With Uterine Leiomyoma.
    Anticancer Res. 2021;41:3001-3010.
    PubMed     Abstract available


  25. KIM JH, Park WH, Suh DH, Kim K, et al
    Calcitriol Combined With Platinum-based Chemotherapy Suppresses Growth and Expression of Vascular Endothelial Growth Factor of SKOV-3 Ovarian Cancer Cells.
    Anticancer Res. 2021;41:2945-2952.
    PubMed     Abstract available


    May 2021
  26. CHOI S, Na K, Kim SW, Kim HS, et al
    Dedifferentiated Mesonephric-like Adenocarcinoma of the Uterine Corpus.
    Anticancer Res. 2021;41:2719-2726.
    PubMed     Abstract available


  27. ZHANG R, Wang T, Lin J
    Synergistic Effect of Bazedoxifene and PARP Inhibitor in the Treatment of Ovarian Cancer Regardless of BRCA Mutation.
    Anticancer Res. 2021;41:2277-2286.
    PubMed     Abstract available


    April 2021
  28. CHECK JH, Check D, Poretta T, Wilson C, et al
    Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma.
    Anticancer Res. 2021;41:2111-2115.
    PubMed     Abstract available


  29. NASSER S, Fotopoulou C, Richter R, Kaulich J, et al
    Prognostic Value and Therapeutic Implications of Pleural Carcinosis and Malignant Pleural Effusion in Advanced Epithelial Ovarian Cancer.
    Anticancer Res. 2021;41:2033-2038.
    PubMed     Abstract available


  30. GADDUCCI A, Simonetti E, Guidoccio F, Manca G, et al
    Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study.
    Anticancer Res. 2021;41:1937-1944.
    PubMed     Abstract available


  31. PANAGOPOULOS I, Andersen K, Ramslien LF, Ikonomou IM, et al
    Therapy-related Myeloid Leukemia With the Translocation t(8;19)(p11;q13) Leading to a KAT6A-LEUTX Fusion Gene.
    Anticancer Res. 2021;41:1753-1760.
    PubMed     Abstract available


    March 2021
  32. YANO M, Miyazawa M, Ogane N, Ogasawara A, et al
    Up-regulation of HDAC6 Results in Poor Prognosis and Chemoresistance in Patients With Advanced Ovarian High-grade Serous Carcinoma.
    Anticancer Res. 2021;41:1647-1654.
    PubMed     Abstract available


  33. KWON HJ, Song SY, Kim HS
    Prominent Papillary Growth Pattern and Severe Nuclear Pleomorphism Induced by Neoadjuvant Chemotherapy in Ovarian Mucinous Carcinoma: Potential for Misdiagnosis as High-grade Serous Carcinoma.
    Anticancer Res. 2021;41:1579-1586.
    PubMed     Abstract available


  34. MEYER HJ, Wienke A, Surov A
    Pre-treatment Apparent Diffusion Coefficient Does Not Predict Therapy Response to Radiochemotherapy in Cervical Cancer: A Systematic Review and Meta-analysis.
    Anticancer Res. 2021;41:1163-1170.
    PubMed     Abstract available


  35. KAYACAN S, Yilancioglu K, Akdemir AS, Kaya-Dagistanli F, et al
    Synergistic Effect of Apigenin and Curcumin on Apoptosis, Paraptosis and Autophagy-related Cell Death in HeLa Cells.
    Anticancer Res. 2021;41:1271-1282.
    PubMed     Abstract available


    February 2021
  36. MIYAMOTO M, Hada T, Ishibashi H, Iwahashi H, et al
    A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes.
    Anticancer Res. 2021;41:1047-1053.
    PubMed     Abstract available


  37. JOCHUM F, Aubry G, Pellerin M, Billard C, et al
    Relevance of Laparoscopic Surgery for Ovarian Cancer in Well-selected Patients: A Propensity-matched Comparison With Laparotomy.
    Anticancer Res. 2021;41:955-965.
    PubMed     Abstract available


  38. MANDATO VD, Torricelli F, Mastrofilippo V, Pirillo D, et al
    Impact of a Province-wide Endometrial Cancer Guideline on Daily Practice.
    Anticancer Res. 2021;41:937-948.
    PubMed     Abstract available


  39. URPILAINEN E, Arima R, Karihtala P, Puistola U, et al
    Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes.
    Anticancer Res. 2021;41:821-828.
    PubMed     Abstract available


  40. KIM HJ, Heo K
    YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation.
    Anticancer Res. 2021;41:671-678.
    PubMed     Abstract available


  41. EGGER EK, Stope MB, Recker F, Konsgen D, et al
    Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options.
    Anticancer Res. 2021;41:999-1004.
    PubMed     Abstract available


    January 2021
  42. DI MARTINO G, Lissoni AA, Ferrari D, DI Meo ML, et al
    Dose-dense Neoadjuvant Chemotherapy With Paclitaxel and Carboplatin in Cervical Cancer: Efficacy on Pathological Response.
    Anticancer Res. 2021;41:497-502.
    PubMed     Abstract available


  43. SHIMIZU Y, Suzuki S, Ukai M, Hattori S, et al
    The Prognostic Significance of Peritumoral Lymphocytes' Band-like Structure in Type II Endometrial Cancer.
    Anticancer Res. 2021;41:249-258.
    PubMed     Abstract available


  44. GADDUCCI A, Cosio S
    The Prognostic Relevance of Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Gynecological Cancer.
    Anticancer Res. 2021;41:9-20.
    PubMed     Abstract available


    December 2020
  45. CHECK JH, Check D, Srivastava MD, Poretta T, et al
    Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life.
    Anticancer Res. 2020;40:6997-7001.
    PubMed     Abstract available


  46. SOPO M, Anttila M, Muukkonen OT, YlA-Herttuala S, et al
    Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.
    Anticancer Res. 2020;40:6923-6931.
    PubMed     Abstract available


  47. LU KW, Yang MD, Peng SF, Chen JC, et al
    Maslinic Acid Induces DNA Damage and Impairs DNA Repair in Human Cervical Cancer HeLa Cells.
    Anticancer Res. 2020;40:6869-6877.
    PubMed     Abstract available


  48. MIYAZAWA M, Yasuda M, Miyazawa M, Ogane N, et al
    Hypoxia-inducible Factor-1alpha Suppression in Ovarian Clear-cell Carcinoma Cells by Silibinin Administration.
    Anticancer Res. 2020;40:6791-6798.
    PubMed     Abstract available


  49. DE BREE E, Katsougkri D, Polioudaki H, Tsangaridou E, et al
    Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?
    Anticancer Res. 2020;40:6769-6780.
    PubMed     Abstract available


  50. FILIPPOV-LEVY N, Davidson B, Reich R
    The Biological Role of the Long Non-coding RNA LINK-A in Ovarian Carcinoma.
    Anticancer Res. 2020;40:6677-6684.
    PubMed     Abstract available


  51. GULIYEVA G, Huayllani MT, Avila FR, Boczar D, et al
    Younger Age as a Risk Factor for Gynecologic Cancer-related Lymphedema: A Systematic Review.
    Anticancer Res. 2020;40:6609-6612.
    PubMed     Abstract available


    November 2020
  52. LEE S, Jun J, Kim WJ, Tamayo P, et al
    WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer.
    Anticancer Res. 2020;40:6017-6028.
    PubMed     Abstract available


  53. HUFFMAN D, Wegner R, Jalil A, Krivak T, et al
    Survival After Primary Surgery Compared With Neoadjuvant Chemotherapy in Early-stage Ovarian Cancer.
    Anticancer Res. 2020;40:6003-6008.
    PubMed     Abstract available


  54. GADDUCCI A, Cosio S, Fruzzetti F
    Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue.
    Anticancer Res. 2020;40:5995-6002.
    PubMed     Abstract available


    October 2020
  55. MITSOPOULOS V, Innamaa A, Lippiatt J, Plevris N, et al
    Radical Surgical Procedures in Advanced Ovarian Cancer and Differences Between Primary and Interval Debulking Surgery.
    Anticancer Res. 2020;40:5869-5875.
    PubMed     Abstract available


  56. CHINCZEWSKI L, Taube ET, Feldhaus FW, DrOge LA, et al
    Angiosarcomas of Primary Gynecologic Origin - A Case Series and Review of the Literature.
    Anticancer Res. 2020;40:5743-5750.
    PubMed     Abstract available


  57. MINAGAWA Y, Ishino K, Wada R, Kudo M, et al
    High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma.
    Anticancer Res. 2020;40:5631-5639.
    PubMed     Abstract available


  58. OH CK, Park JJ, Ha M, Heo HJ, et al
    LRRC17 Is Linked to Prognosis of Ovarian Cancer Through a p53-dependent Anti-apoptotic Function.
    Anticancer Res. 2020;40:5601-5609.
    PubMed     Abstract available


  59. HSIEH Y, Tseng JJ
    Azidothymidine (AZT) Inhibits Proliferation of Human Ovarian Cancer Cells by Regulating Cell Cycle Progression.
    Anticancer Res. 2020;40:5517-5527.
    PubMed     Abstract available


  60. YOSHINO AI, Kobayashi E, Kodama M, Hashimoto K, et al
    Oncological and Reproductive Outcomes of Abdominal Radical Trachelectomy.
    Anticancer Res. 2020;40:5939-5947.
    PubMed     Abstract available


  61. SHIBA S, Wakatsuki M, Ohno T, Nakano T, et al
    Differences in Linear Energy Transfer Affect Cell-killing and Radiosensitizing Effects of Spread-out Carbon-ion Beams.
    Anticancer Res. 2020;40:5497-5502.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: